HIV-1 Subtype Diversity Based on Envelope C2V3 Sequences from Kenyan Patients on Highly Active Antiretroviral Therapy

被引:0
|
作者
Kitawi, Rose C. [1 ,2 ]
Nzomo, Timothy [1 ,2 ]
Mwatelah, Ruth S. [1 ,2 ]
Aman, Rashid [1 ,3 ]
Kimulwo, Maureen J. [1 ,2 ]
Masankwa, Geoffrey [1 ,3 ]
Lwembe, Raphael M. [4 ]
Okendo, Javan [5 ]
Ogutu, Bernhards [1 ,4 ]
Ochieng, Washingtone [1 ,4 ,6 ]
机构
[1] Strathmore Univ, Ctr Res Therapeut Sci, Nairobi, Kenya
[2] Inst Trop Med & Infect Dis, Nairobi, Kenya
[3] African Ctr Clin Trials, Nairobi, Kenya
[4] Kenya Govt Med Res Ctr, Nairobi, Kenya
[5] Kenyatta Univ, Nairobi, Kenya
[6] Harvard Univ, Sch Publ Hlth, Immunol & Infect Dis Dept, Boston, MA 02115 USA
基金
英国惠康基金;
关键词
GENETIC DIVERSITY; TYPE-1; SUBTYPES;
D O I
10.1089/aid.2014.0306
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There is a continuous need to genetically characterize the HIV strains in circulation in order to assess interventions and inform vaccine discovery. We partially sequenced the envelope C2V3 gene from a total of 59 Kenyan patients on highly active antiretroviral treatment (HAART) and determined HIV subtypes using both the JPHMM subtyping tool and the phylogenetic method. HIV-1 subtype A1 was the predominant strain in circulation, representing 65.5% and 74.5% of all isolates as determined by JPHMM and phylogenetic methods, respectively. Subtypes C and D were the next most prevalent pure strains at 9.1% each by both methods. JPHMM identified 9.1% of the isolates as recombinant. Four isolates had short sequences not covering the entire C2V3 region and were thus not subtyped. From this study, subtype A viruses are still the predominant HIV-1 strains in local circulation in Kenya. Constant surveillance is needed to update molecular trends under continuing HAART scale-up.
引用
收藏
页码:452 / 455
页数:4
相关论文
共 50 条
  • [31] Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy
    Dinoso, J. B.
    Kim, S. Y.
    Wiegand, A. M.
    Palmer, S. E.
    Gange, S. J.
    Cranmer, L.
    O'Shea, A.
    Callender, M.
    Spivak, A.
    Brennan, T.
    Kearney, M. F.
    Proschan, M. A.
    Mican, J. M.
    Rehm, C. A.
    Coffin, J. M.
    Mellors, J. W.
    Siliciano, R. F.
    Maldarelli, F.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (23) : 9403 - 9408
  • [32] Increasing Diversity of HIV-1 Based on Envelope and Pol-RT Sequences of Viruses Circulating among Antiretroviral Experienced Kenyans
    Kitawi, Rose C.
    Nzomo, Timothy
    Sada, Ruth
    Kimulwo, Maureen
    Masankwa, Geoffrey
    Ogutu, Bernhards
    Aman, Rashid
    Ochieng, Washingtone
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 : A182 - A183
  • [33] HIV-1 provirus in the peripheral CD4-positive T lymphocytes from the HIV-1 infected patients under highly active antiretroviral therapy
    Kaneda, T
    Hagiwara, T
    Hattori, J
    Utsumi, M
    [J]. XIV INTERNATIONAL AIDS CONFERENCE: BASIC SCIENCES, 2002, : 61 - 64
  • [34] Diversity in HIV-1 envelope V1-V3 sequences early in infection reflects sequence diversity throughout the HIV-1 genome but does not predict the extent of sequence diversity during chronic infection
    Sagar, M
    Kirkegaard, E
    Lavreys, L
    Overbaugh, J
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (05) : 430 - 437
  • [35] Presence of minor drug-resistant mutations in HIV-1 subtype C patients failing antiretroviral therapy
    Wallis, C.
    Stevens, W.
    Papathanasopolous, M.
    Simen, B. B.
    Braverman, M.
    Egholm, M.
    Pillay, V.
    Morris, L.
    Ndung'u, T.
    Gordon, M.
    Sakwa, J.
    [J]. ANTIVIRAL THERAPY, 2008, 13 (04) : A118 - A118
  • [36] Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy
    Rockstroh, JK
    Mocroft, A
    Soriano, V
    Tural, C
    Losso, MH
    Horban, A
    Kirk, O
    Phillips, A
    Ledergerber, B
    Lundgren, J
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (06): : 992 - 1002
  • [37] Performance of Genotypic Tools for Prediction of Tropism in HIV-1 Subtype C V3 Loop Sequences
    Gupta, Soham
    Neogi, Ujjwal
    Srinivasa, Hiresave
    Shet, Anita
    [J]. INTERVIROLOGY, 2015, 58 (01) : 1 - 5
  • [38] HIV-1 V1V2 envelope sequences influence neurotropism and differ between demented and nondemented patients
    Power, C
    McArthur, JC
    Glass, JD
    Langelier, T
    Wehrly, K
    Chesebro, B
    [J]. NEUROLOGY, 1997, 48 (03) : 2006 - 2006
  • [39] Dental implants in individuals living with HIV-1: Results from a prospective study in patients undergoing highly active antiretroviral therapy
    Vidal, Fabio
    Peres, Rafael Vidal
    de Souza, Rodrigo Carvalho
    Goncalves, Cristiane
    Pavan, Priscila
    Goncalves, Lucio Souza
    [J]. SPECIAL CARE IN DENTISTRY, 2022, 42 (02) : 112 - 119
  • [40] Predictors of Attrition and Immunological Failure in HIV-1 Patients on Highly Active Antiretroviral Therapy from Different Healthcare Settings in Mozambique
    Palladino, Claudia
    Briz, Veronica
    Maria Bellon, Jose
    Bartolo, Ines
    Carvalho, Patricia
    Camacho, Ricardo
    Angeles Munoz-Fernandez, M.
    Bastoss, Rui
    Manuels, Rolanda
    Casanovas, Jose
    Taveira, Nuno
    [J]. PLOS ONE, 2013, 8 (12):